No­var­tis ac­cus­es 2 AveX­is founders of al­ter­ing da­ta, stonewalling probe — but ex-CSO blasts back

No­var­tis has re­spond­ed to the FDA’s ques­tions on the AveX­is da­ta ma­nip­u­la­tion scan­dal, blam­ing two “se­nior” ex­ecs at AveX­is who had helped found the com­pa­ny and re­mained “fix­tures” at the biotech for their role in stonewalling the probe and de­lay­ing their re­sponse. And the phar­ma gi­ant promised that it would ramp up new plans to re­train AveX­is staff and ac­cel­er­ate an in­te­gra­tion plan to the glob­al or­ga­ni­za­tion to make sure it nev­er hap­pened again.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER